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Influenza is a yearly seasonal threat and major cause of mortality, particularly in children and the elderly. Although neuraminidase inhibitors and M2 protein 
blockers are used for medication, drug resistance has gradually emerged. Thus, the development of effective anti-influenza drugs targeting different constituent 
proteins of the virus is urgently desired. In this light, we carried out molecular docking to predict the binding modes of anti-influenza diketo acid inhibitors in the 
active site of the PAN subunit of the metalloenzyme RNA polymerase of influenza virus. The calculations suggested that the dianionic forms of the diketo acids 
should chelate the dinuclear manganese center as dinucleating ligands and sequester it. They also indicated that the diketo acid derivatives with larger hydrophobic 
substituents should block a hydrophobic cavity in the active site more tightly. These assumptions could adequately explain the enzyme inhibition by these 
compounds. Furthermore, we designed potential inhibitors by lead optimization of a diketo acid inhibitor from the thermodynamic points of view. Molecular 
docking results showed that the newly designed diketo acid derivatives might inhibit the metalloenzyme RNA polymerase more strongly than the lead inhibitor. 
 
 






An epidemic of influenza is a yearly seasonal threat. On the other hand, the 
2009 H1N1 swine flu unexpectedly ran riot around the world. It is a major 
cause of mortality, particularly in children and the elderly. Although several 
anti-influenza drugs, neuraminidase inhibitors, and M2 protein blockers are 
used for medication against this virus, drug resistance has gradually emerged 
[1-3]. In addition, the supply of viral vaccine is inadequate. Thus, the 
development of effective anti-influenza drugs targeting different constituent 
proteins of the virus is urgently desired [4]. The influenza virus is a segmented 
negative-stranded RNA virus. The synthesis of influenza virus mRNA occurs 
in the nuclei of infected cells and is catalyzed by a viral RNA polymerase 
consisting of the three subunits, PA, PB1, and PB2 [5]. This RNA-dependent 
enzyme possesses endonuclease and RNA transcriptase activities, and is hence 
essential for viral replication. Although the RNA polymerase is highly 
conserved among influenza A, B, and C viruses, no homologue has been found 
in mammalian cells [6]. Thus, a viral RNA polymerase is a safe target in terms 
of selective toxicity. 
 
Tomassini  et al. reported that a series of diketo acid derivatives, 1-8, are 
effective inhibitors of influenza viral replication in both in vitro cell culture 
replication assays and in vivo mouse challenge model, without exhibiting any 
cytotoxicity (Figure 1) [7, 8]. Given that the action is due to the inhibition of 
the endonuclease activity of the viral RNA polymerase, the enzyme is currently 
regarded as a promising target for anti-influenza virus agents [9]. Recently, 
studies on the crystallography of the PA subunit have revealed that PAN, the N-
terminal domain of PA, contains one Mg ion or two Mn ions in the 
endonuclease active site [10–12]. The endonuclease activity of the PAN subunit 
with two Mn ions is inhibited by the diketo acid derivative 5  [12]. This 
suggests that 1-8 should bind tightly to the active site of the PAN subunit and 
inhibit endonuclease activity. Given that compounds 9-12, which lack a β-
diketone or carboxylic acid group, do not show inhibition of endonuclease 
activity, the diketo acid moiety is a pharmacophore for the anti-influenza virus 
activity  [13]. In addition to the significance of the pharmacophore, it is 
suggested that the inhibitory activity should depend on the hydrophobicity of 
the aliphatic substituents. Hence, the interaction between the hydrophobic 
substituents and non-polar residues in the active site should be associated with 
enzyme inhibition. 
 
Our objective in this study was to rationalize the inhibitory action of the diketo 
acid derivatives to the PAN subunit of the metalloenzyme RNA polymerase and 
to design potential diketo acid inhibitors by structure-based and computer-
aided modeling approach. Hence, we carried out molecular docking to predict 
how the anti-influenza virus diketo acid derivatives would bind to the active 
site of the PAN subunit. To our knowledge, this is the first modeling study to 
elucidate the interaction of the PAN subunit with anti-influenza virus diketo 
acid derivatives. BIOINFORMATION  open access 
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Figure 1: Series of diketo acid derivatives and their IC50 values (μM) for 
transcription inhibition activity. 
 
Methodology: 
The geometry optimization and electrostatic potential calculation of the 
dianionic forms of diketo acid derivatives were performed using Gaussian 03 
with the B3LYP hybrid functional and the 6-31+G(d) basis set [14]. The 
restrained electrostatic potential charge fitting of the electrostatic potentials of 
the optimized structures was carried out with the antechamber module in 
AMBER9 [15]. The crystal structure (ID: 2w69, chain D) of the PAN subunit 
with two Mn ions was obtained from PDB [12]. All water molecules and 
sulfate ions were stripped from the coordinates of the crystal structure, and then 
hydrogen atoms were added through WHATIF web server 
(http://swift.cmbi.ru.nl/servers/html/prepdock.html). The Gasteiger charges and 
+2.0 charges were assigned for the amino acids and two Mn ions, respectively. 
A grid of 30.0 Å x 30.0 Å x 30.0 Å with 0.375 Å spacing was calculated using 
AutoGrid. Automated ligand-flexible and receptor-flexible molecular docking 
calculations were performed and analyzed using AutoDock 4.2 and 
AutoDockTools  [16]. One hundred docking runs for every compound were 
performed. Each docking calculation consisted of 25 million energy 
evaluations (long mode) using the Lamarckian genetic algorithm method. 
Maximum number of generations was set to 270,000. All the other parameters 
were set by default. The docking results were clustered on the basis of root-
mean-square deviation between the Cartesian coordinates of the atoms using 
2.0 Å cutoff, and were ranked on the basis of the binding free energy (BFE, 
kcal/mol) calculated by AutoDock 4.2. 
 
 
Figure 2: Optimized structures and energies of four tautomers of 8. Gray, red, 
and white spheres depict carbon, oxygen, and hydrogen atoms, respectively. 
 
Results and Discussion: 
Prior to the molecular docking, we evaluated the stability of four tautomers of 
the simplest diketo acid 8 according to density functional theory (DFT). The 
geometry optimization of the tautomers was carried out with the B3LYP hybrid 
functional and 6-31G(d) basis set [14]. As shown in Figure 2, the optimized 
structures and energies indicated that the enol forms 8a (E = –495.04062 a.u.) 
and 8b (E = –495.03833 a.u.) were more stable than the keto forms 8c (E = –
495.03573 a.u.) and 8d (E = –495.02792 a.u.). Furthermore, the enol form with 
an intramolecular hydrogen bond between the enol and carboxylic acid groups 
(8a) was more stable than the one without the intramolecular hydrogen bond 
(8b). As a result, 8a was the most stable tautomer, suggesting that its 
population is the highest. Given the pKa of the terminal carboxylic acid of 
diketo acids (pKa ~ 4) [17], potential chelating ability of the β-diketone group, 
structure-activity relationship, and DFT results, it is the dianionic forms of 
diketo acid derivatives that should readily coordinate with the two Mn ions in 
the active site of the PAN subunit, as shown in Figure 3. The driving forces of 
the interaction are likely to be the chelate effect, enthalpically favorable 
electrostatic interaction between the Mn
2+ and oxo ions, and the entropically 
favorable release of water molecules generated by the acid-base reaction of the 
diketo acids with the coordinated hydroxo bases. Sequestering the metal ions 
should disturb the access of the substrate, and thus inhibit enzyme function 
[18]. In addition, the hydrophobic interaction between the substituents of the 
diketo acid derivatives and the residues in the active site should be 
systematically related to the affinities and inhibitory activities of the diketo 
acid derivatives. Hence, we predicted the binding modes of the dianionic forms 
of the diketo acid derivatives in the active site of the PAN subunit having two 
Mn ions.  
 
 
Figure 3: Plausible coordination mechanism of diketo acid derivatives to 




Figure 4: (A) Top-ranked flexible-ligand and rigid-receptor docking poses of 1 
(cyan), 2 (green), and 3 (orange); (B) Top-ranked flexible-ligand and rigid-
receptor docking poses of 5 (cyan), 6 (green), 7 (orange), and 8 (purple); (C) 
Top-ranked flexible-ligand and rigid-receptor docking pose of 4; (D) Flexible-
ligand and flexible-Arg84 docking pose of 4. 
 
The top-ranked docking poses for compound 1-3 and 5-8 in terms of flexible-
ligand and rigid-receptor docking are shown in Figures 4A & 4B, respectively, 
and their BFEs are listed in Table 1 (see Supplementary material). As 
expected, the dianionic moieties were predicted to chelate the dinuclear Mn 
center as dinucleating ligands. For 1-3, the chlorobenzyl groups were exposed 
on the outside of the active site, and they had contact with Phe105 and Arg84 at 
the edge. On the other hand, the aryl/cyclohexyl piperidine substituents were in 
a deeper position, and they had van der Waals contacts with Tyr24 and Ala20. 
The burial of the hydrophobic groups upon binding should result in desolvation 
entropy gain because of the release of water molecules into the bulk solution. 
No hydrogen bond was seen for the piperidine nitrogens. Thus, the right side of 
the active site was blocked by chelation and hydrophobic interaction, both of 
which should contribute to higher inhibitory effect. The poorer inhibitory effect 
for  5-8 is most likely due to the lack of aliphatic substituents that interact 
hydrophobically with any amino acid residue in the deeper position. The top-
ranked docking pose for 4 was different from that for the others mentioned 
above. The only carboxylate group coordinated to and bridged two Mn ions, 
and the biphenyl substituent interacted with a hydrophobic pocket on the left 
side (Figure 4C). However, diketo acid 4 need not be of diketonate form in this 
docking pose, and thus its BFE is overestimated. This unexpected improper 
docking result could arise from steric hindrance between Arg84 and the 
biphenyl substituent. Thus, a molecular docking taking into account the 
flexibility of Arg84 was carried out. There was space to pack the Arg84 
residue, and steric hindrance was avoided by the inversion of the Arg84 
residue. This resulted in the chelation by the dianionic form of 4 as the 
dinucleating ligand, as shown in Figure 4D.  BIOINFORMATION  open access 
 
ISSN 0973-2063 (online) 0973-8894 (print)     
Bioinformation 6(6): 221-225 (2011)  223             © 2011 Biomedical Informatics
 
 
Figure 5: Plots and regression lines of logIC50s of 1-8 versus their binding free 
energies with rigid-receptor (open circles and dashed line) and flexible-Arg84 
receptor (filled circles and solid line) models. 
 
In the light of the flexibility of Arg84, molecular docking calculations were 
also performed for the other diketo acid derivatives. The logIC50 values for 
transcription inhibition activity and the BFEs of 1-8 when using a flexible-
Arg84 receptor model are listed in Table 1. The plots of the logIC50s and BFEs 
shown in Figure 5 reveal that the logIC50s of 1-8 are well correlated with the 
corresponding BFEs. In particular, it is noted that the correlation in the case of 
flexible-Arg84 dockings (R = 0.91) was superior to that in the case of rigid-
receptor dockings (R = 0.89). In addition, molecular docking calculations 
including the flexibilities of Arg84 and the residues adjacent to Arg84 were 
also performed to test if the correlation could be improved by using a receptor 
model with two or three flexible residues. The correlations resulting from 
flexible-Arg84-Tyr24 (R = 0.79) and flexible-Arg84-Tyr24-Trp88 dockings (R 
= 0.64) were lower than those resulting from the rigid-receptor and flexible-
Arg84 dockings (Figure S1, see Supplementary material). This suggests that 
Arg84 is a key residue in predicting the binding mode. 
 
 
Figure 6: Newly designed diketo acid derivatives. 
 
On the basis of our predicted binding models, we propose potential diketo acid 
inhibitors 13-15, as shown in Figure 6, by lead optimization of 1. Chemical 
functionalities were introduced from the viewpoint of enthalpy and entropy of 
binding, which determine the Gibbs energy of binding (i.e., binding affinity). 
The introduction of a hydrogen bond donor/acceptor to establish favorable 
enthalpic interaction with the target was considered. Figure 7A shows the 
flexible-Arg84 docking pose of 1. It was found that the proton donor residue 
Arg84 was conveniently close to the chlorobenzyl piperidine moiety. This 
suggested that the replacement of the methylene group with a carbonyl group 
as a proton acceptor might result in a favorable hydrogen bond. The top-ranked 
docking pose of 13 with the flexible-Arg84 receptor showed a hydrogen bond 
between its carbonyl group and Arg84 (Figure 7B). The introduction of the 
carbonyl group lowers the BFE of flexible-Arg84 docking in 13 (–13.31 
kcal/mol) relative to that in 1 (–12.92 kcal/mol). Furthermore, it was inferred 
that replacement of the carbonyl group with a sulfonyl group could result in a 
more favorable hydrogen bond. The top-ranked rigid-receptor and flexible-
Arg84 docking poses of 14 are shown in Figures 7C and 7D, respectively. The 
docking pose of 14 with the flexible-Arg84 receptor also showed a hydrogen 
bond between its sulfonyl group and Arg84. The BFE of flexible-Arg84 
docking in 14 was lower (–14.21 kcal/mol) than that in 13, suggesting that in 
the docking models, the sulfonyl group might be better than the carbonyl group 
as the hydrogen acceptor with higher affinity. Entropic optimization by 
increasing hydrophobicity was derived by the careful visual inspection of the 
docking results. From a comparison of the top-ranked docking pose (BFE = –
13.23 kcal/mol, Figure 7C) of 14 with the second top-ranked pose (BFE = –
13.22 kcal/mol, Figure 8A) when using the rigid-receptor model, we found that 
there was room for packing an additional phenyl ring in the deep cavity. Thus, 
compound 15 was designed by introducing a diphenylmethyl group, commonly 
found in marketed drugs, in place of the benzyl group. The top-ranked rigid-
receptor (BFE = –14.39 kcal/mol) and flexible-Arg84 docking poses (BFE = –
14.90 kcal/mol) of 15 are shown in Figures 8B and 8C, respectively. The 
docking pose of 15 when using the flexible-Arg84 receptor model exhibited a 
hydrogen bond between its sulfonyl group and Arg84, as well as a hydrophobic 
contact of the diphenylmethyl group in the deep cavity. Few conformational 
differences were observed between the top-ranked rigid-receptor and flexible-
Arg84 docking poses of 15 and between the poses of their corresponding 
Arg84 residues. This suggests the adequacy of the positions for the introduction 
of the hydrogen bond acceptor and the hydrophobic substituent. As a result, the 
BFEs of 15 demonstrated the highest affinities among all the diketo acid 
derivatives when using both the rigid-receptor and flexible-Arg84 receptor 
models. The inhibitory activity of 15 might increase by a few orders of 




Figure 7: (A) Top-ranked flexible-ligand and flexible-Arg84 docking pose of 
1; (B) Top-ranked flexible-ligand and flexible-Arg84 docking pose of 13; (C) 
Top-ranked flexible-ligand and rigid-receptor docking pose of 14; (D) Top-
ranked flexible-ligand and flexible-Arg84 docking pose of 14. 
 
 
Figure 8: (A) Second top-ranked flexible-ligand and rigid-receptor docking 
pose of 14; (B) Top-ranked flexible-ligand and rigid-receptor docking pose of 
15; (C) Top-ranked flexible-ligand and flexible-Arg84 docking pose of 15. 
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Conclusion: 
In this work, we proposed the binding mode of anti-influenza diketo acid 
derivatives in the active site of the PAN subunit of the RNA polymerase, of the 
influenza virus, by molecular docking. The calculations suggested that the 
dianionic forms, of the diketo acids, should chelate the dinuclear Mn center as 
dinucleating ligands and sequester it. In addition, they indicated that the 
aliphatic substituents of the diketo acid derivatives should properly block the 
hydrophobic cavity in the active site, and thus inhibit endonuclease activity. 
The accuracy of the predicted binding modes was validated by the excellent 
correlation between the logIC50s of the diketo acid derivatives and the 
corresponding BFEs. Potential diketo acid inhibitors were designed from the 
thermodynamic point of view by structure-guided and computer-assisted 
modeling approach. The critical residue for the lead optimization of diketo acid 
derivatives is likely to be the proton donor Arg84. The molecular docking 
results showed that the newly designed diketo acid derivatives with the proton 
acceptor of a carbonyl or sulfonyl group might inhibit the metalloenzyme RNA 
polymerase more strongly than the lead compound. We hope that our study can 
contribute to the development of potent influenza virus inhibitors targeting the 
RNA polymerase, which is essential for viral replication. 
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Table 1: The logIC50s and calculated BFEs with rigid-receptor and flexible-Arg84 receptor models for the diketo acid derivatives. 
Compds logIC50
a  BFE in rigid receptor, kcal/mol  BFE in flexible-R84 receptor, kcal/mol 
1  –6.5 –13.14  –12.92 
2  –6.7 –12.98  –12.96 
3  –6.5 –13.74  –13.01 
4  –5.4 –13.01  –12.14 
5  –4.7 –11.40  –11.78 
6  –4.5 –12.12  –12.52 
7  –4.3 –11.43  –11.63 
8  –3.5 –11.36  –11.40 
13   –12.96  –13.31 
14   –13.23  –14.21 
15   –14.39  –14.90 




Figure S1: Plots and regression lines of logIC50s of 1-8 versus their binding free energies with flexible-Arg84-Tyr24 receptor (open squares and dashed line) and 
flexible-Arg84-Tyr24-Trp88 receptor (filled squares and solid line) models. 
 
 
 
 
 
 
 
 
  